Bohnsack B L, Szabo M, Kilen S M, Tam D H, Schwartz N B
Department of Neurobiology and Physiology, Northwestern University, Evanston, Illinois 60208, USA.
Biol Reprod. 2000 Mar;62(3):636-41. doi: 10.1095/biolreprod62.3.636.
Previous in vitro and in vivo studies from our laboratory showed that progesterone (P(4)), corticosterone (B), and testosterone (T) increase intracellular content and release of FSH in the anterior pituitary. Activin (Act) and inhibin (Inh) are structurally related proteins with antagonistic actions, as Act stimulates and Inh inhibits FSH secretion from the anterior pituitary. Together with follistatin (FS), a protein that bioneutralizes Act, they form an autocrine-paracrine loop in the anterior pituitary that tightly regulates FSH secretion. The objective of the present study was to test the hypothesis that P(4), B, and T modulate this autocrine-paracrine loop to favor increased FSH secretion. If Act were to mediate steroid-induced FSH release, FS would be expected to block these effects. To test this interaction, cell cultures were prepared from anterior pituitaries of male and female rats, and treated with Act, B, P(4), or T in the absence or presence of FS. Act, B, P(4), and T increased FSH release; FS suppressed both basal and Act- and steroid-stimulated FSH release to approximately 50% below basal levels. Cell cultures from anterior pituitary of female rats were used to compare the interaction of incremental concentrations of FS on dose-related Act- and P(4)-stimulated FSH release. With increasing concentrations of Act, the FS-induced suppression of FSH release was attenuated and eventually abolished; in contrast, maximally stimulatory concentrations of P(4) did not fully overcome the FS-induced suppression of FSH release. The effects of P(4), B, and Act in the presence and absence of estradiol on steady-state mRNA levels of FSHbeta, Actbeta(B), and FS were determined in primary pituitary cell cultures from metestrous female rats by reverse transcription-polymerase chain reaction. Whereas Act, P(4), B increased FSHbeta mRNA levels, only Act raised the level of FS mRNA, and neither steroid increased Actbeta(B) mRNA. The results support the hypothesis that endogenous Act is a common mediator of the action of P(4), B, and T in the rat primary anterior pituitary cell culture. We conclude that the stimulation of FSH release and intracellular content in the gonadotroph by P(4), B, and T is mediated, in part, by Act and involves modulation of a tightly regulated Act/FS autocrine-paracrine loop.
我们实验室之前的体外和体内研究表明,孕酮(P(4))、皮质酮(B)和睾酮(T)可增加垂体前叶中促卵泡激素(FSH)的细胞内含量并促进其释放。激活素(Act)和抑制素(Inh)是结构相关但作用相反的蛋白质,激活素刺激垂体前叶分泌FSH,而抑制素则抑制其分泌。激活素与卵泡抑素(FS)(一种可中和激活素生物活性的蛋白质)共同作用,在垂体前叶形成自分泌 - 旁分泌环路,从而严格调控FSH的分泌。本研究的目的是验证以下假设:P(4)、B和T通过调节这一自分泌 - 旁分泌环路来促进FSH分泌增加。如果激活素介导类固醇诱导的FSH释放,那么卵泡抑素应该能够阻断这些作用。为了验证这种相互作用,我们从雄性和雌性大鼠的垂体前叶制备细胞培养物,并在有无卵泡抑素的情况下分别用激活素、B、P(4)或T进行处理。激活素、B、P(4)和T均可增加FSH释放;卵泡抑素可将基础状态以及激活素和类固醇刺激后的FSH释放抑制至基础水平以下约50%。我们使用来自雌性大鼠垂体前叶的细胞培养物来比较不同浓度卵泡抑素对剂量相关的激活素和P(4)刺激的FSH释放的相互作用。随着激活素浓度的增加,卵泡抑素诱导的FSH释放抑制作用逐渐减弱并最终消失;相反,最大刺激浓度的P(4)并不能完全克服卵泡抑素诱导的FSH释放抑制作用。我们通过逆转录 - 聚合酶链反应,在动情后期雌性大鼠的原代垂体细胞培养物中,测定了在有或无雌二醇情况下P(4)、B和激活素对FSHβ、激活素β(B)和卵泡抑素稳态mRNA水平的影响。虽然激活素、P(4)、B均可增加FSHβ mRNA水平,但只有激活素可提高卵泡抑素mRNA水平,且两种类固醇均未增加激活素β(B) mRNA水平。这些结果支持以下假设:内源性激活素是P(4)、B和T在大鼠原代垂体前叶细胞培养物中发挥作用的共同介质。我们得出结论,P(4)、B和T对促性腺细胞中FSH释放和细胞内含量的刺激作用,部分是由激活素介导的,并且涉及对一个严格调控的激活素/卵泡抑素自分泌 - 旁分泌环路的调节。